Berberine |
Coptis chinensis
|
HCA 7 cells |
10–100 µM |
In vitro
|
Result in a downregulation of 33 genes differently involved in cell cycle, differentiation and EMT |
Palmieri et al. (2019)
|
Evodiamine |
Evodia rutaecarpa
|
HCT 116 cells |
5–15 µM |
In vitro
|
Inhibit the proliferation of cells, cause accumulation of cells in S and G2/M phases, and reduce the levels of the secreted form of AMF |
Zhao et al. (2015)
|
Matrine |
Sophora flavescens
|
SW 480 cells |
0.25–1.25 mM |
In vitro
|
Trigger cell apoptosis and G0/G1 cell cycle arrest via mediation of microRNA-22 |
Liu et al. (2020a)
|
SW 620 cells |
0.25–1.25 mM |
In vitro
|
Oxymatrine |
Sophora flavescens
|
RKO cells |
0.125–8 mg/ml |
In vitro
|
Inhibit the migration of human colorectal carcinoma via the inhibition of PAI-1 and the TGF-β1/Smad signaling pathway |
Wang et al. (2017)
|
Coptisine |
Coptis chinensis
|
HCT 116 cells |
2.81–140.54 µM |
In vitro
|
Induce apoptosis of cells by the PI3K/Akt and mitochondrial-related apoptosis pathway |
Han et al. (2018)
|
BALB/c mice |
50–150 mg/kg |
In vivo
|
Lycorine |
Lycoris plants |
RKO cells |
10–50 µM |
In vitro
|
Induce the activation of the caspase-dependent mitochondrial apoptotic pathway |
Wu et al. (2018)
|
SW 480 cells |
10–50 µM |
In vitro
|
Piperine |
Piper longum L. |
HT 29 cells |
1.25 and 2.5 μg/ml |
In vitro
|
Enhance radiosensitization by inducing the cells to apoptosis |
Shaheer et al. (2020)
|
Sophoridine |
Sophora alopecuroide
|
HCT 116 cells |
40–160 µM |
In vitro
|
Inhibits human colorectal cancer progression via targeting the MAPKAPK2 |
Wang et al. (2019) |
SW 480 cells |
40–160 µM |
In vitro
|
RKO cells |
40–160 µM |
In vitro
|
Tetrandrine |
Stephaniae tetrandrae radix |
SW620 cells |
0.2–50 µM |
In vitro
|
Suppress adhesion, migration, and invasion via the inhibition of nuclear factor-kappa B, MMP-2, and MMP-9 |
Juan et al. (2018)
|
Vinblastine |
Catharanthus roseus
|
HCT 116 cells |
0.3–2.5 nM |
In vitro
|
Inhibit tumor growth and promote angiogenesis factors |
Auyeung et al. (2014)
|
BALB/c mice |
0.25 mg/kg |
In vivo
|
Homoharringtonine |
Cephalotaxus fortunei
|
LoVo cells SW480 cells Caco-2 cells |
0.1–0.4 µM |
In vitro
|
Suppress cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways |
Shi et al. (2020) |
0.1–0.4 µM |
In vitro
|
0.1–0.4 µM |
In vitro
|
BALB/C mice |
0.25–1 mg/kg |
In vivo
|
Curcumin |
Curcuma longa L. |
HCT 8 cells |
10 µM |
In vitro
|
Downregulate KCNQ1OT1 expression, thus reversing cisplatin resistance in CRC cells |
Zheng et al. (2021)
|
Nude mice |
1 g/kg/week |
In vivo
|
Resveratrol |
Veratrum Linn.
|
DLD-1 cells Caco-2 cells |
40–120 µM |
In vitro
|
Regulate several genes involved in the modulation of apoptosis such as PMAIP1, BID, and ZMAT3 |
Gavrilas et al. (2019)
|
40–120 µM |
In vitro
|
Quercetin |
Sophora japonica L. |
Wistar rats |
50 mg/kg |
In vivo
|
Suppress DNA damage and induce DNA repair and increase the levels and activities of enzymic, as well as the nonenzymic antioxidants |
Darband et al. (2020)
|
Tanshinone II A |
Salvia miltiorrhiza Bge. |
SW 620 cells |
0.5–10 μg/ml |
In vitro
|
Suppress SW620 proliferation and induce apoptosis |
Xue et al. (2019)
|
Luteolin |
Reseda odorata
|
HT-29 cells SW480 cells SW620 cells LoVo cells |
10–100 µM |
In vitro
|
Upregulate miR-384 and downregulate the PTN expression level both in CRC cells and tissues |
Yao et al. (2019)
|
10–100 µM |
In vitro
|
10–100 µM |
In vitro
|
10–100 µM |
In vitro
|
BALB/c mice |
100 mg/kg |
In vivo
|
Genistein |
Puerariae lobatae Radix |
SW480 cells |
25–100 µM |
In vitro
|
Increase the expression of TGF-β1 and lncRNA TTTY18, followed by upregulated Ki-67, serum, and SGK1 |
Chen et al. (2020a)
|
Baicalin |
Scutellariae Radix |
RKO cells |
50, 100 μg/ml |
In vitro
|
Inhibit cell growth, migration, and invasion and induce cell apoptosis, induce cell cycle arrest in the G1 phase, and suppress both endogenous and exogenous TGFβ1-induced EMT |
Yang et al. (2020)
|
HCT 116 cells |
50, 100 μg/ml |
In vitro
|
BALB/c mice |
100, 200 mg/kg |
In vivo
|
Shikonin |
Arnebiae Radix |
SW 480 cells |
2.5–15 µM |
In vitro
|
Induce mitochondria-mediated apoptosis by Bcl-2 family protein and increase the intracellular ROS |
Liang et al. (2017)
|
HCT 116 cells |
2.5–15 µM |
In vitro
|
BALB/c mice |
3, 6 mg/kg |
In vivo
|
Emodin |
Rhei Radix et Rhizoma |
HCT 116 cells |
15–60 μg/ml |
In vitro
|
Block the growth and invasion of CRC cells by restraining VEGFR2 |
Dai et al. (2019a)
|
BALB/c mice |
20–80 mg/kg |
In vivo
|
Cordycepin |
Cordyceps sinensis
|
HCT 116 cells |
62.5–540 µM |
In vitro
|
Inhibit cell growth by the endogenous Bax-dependent mitochondrial apoptosis pathway |
Li et al. (2019b)
|
Paeoniflorin |
Paeonia lactiflora Pall. |
HCT 116 cells |
2.5–40 mM |
In vitro
|
Inhibit migration and invasion and suppress cell metastatic potential and decrease the expression of HDAC2 and vimentin, increasing E-cadherin |
Zhang et al. (2018)
|
SW 480 cells |
2.5–40 mM |
In vitro
|
BALB/c mice |
1 g/kg |
In vivo
|
Ginsenoside Rh3 |
Ginseng Radix et Rhizoma |
SW 1116 cells |
60–240 μg/ml |
In vitro
|
Inhibit proliferation and increase the ratio of apoptotic cells, mRNA, and protein of caspase3 |
Cong et al. (2020)
|
BALB/c mice |
100, 200 mg/kg |
In vivo
|
Andrographolide |
Andrographis Herba |
HCT 116 cells |
5–100 µM |
In vitro
|
Anti-TNF-α-induced IL-8 by inhibition of NADPH oxidase/ROS/NF-κB and Src/MAPKs/AP-1 signaling pathways |
Yuan et al. (2018)
|
Ursolic acid |
Ligustri lucidi Fructus |
HCT 116 cells HCT 8 cells |
10–40 µM |
In vitro
|
Suppress the invasive by regulating the TGF-β1/ZEB1/miR-200c signaling pathway |
Zhang et al. (2019a)
|
10–40 µM |
In vitro
|
Celastrol |
Tripterygium wilfordii
|
HCT 116 cells |
2.5–10 µM |
In vitro
|
Inhibit proliferation, migration, and NOS activity in the cytoplasm and inhibit growth and migration |
Gao et al. (2019)
|
HT 29 cells |
2.5–10 µM |
In vitro
|
Bufalin |
Bufonis venenum
|
HCT 116 cells |
0.1–50 µM |
In vitro
|
Reverse acquired drug resistance by inhibiting stemness in colorectal cancer cells |
Sun et al. (2017)
|
LoVo cells |
0.1–50 µM |
In vitro
|
BALB/c mice |
1 mg/kg |
In vivo
|
Norcantharidin |
Mylabris phalerata Pallas. |
HT 29 cells |
5, 10 μg/ml |
In vitro
|
Cause proapoptotic and antiglycolytic effects through modulation of Fam46c expression and inhibition of ERK1/2 signaling |
Zhang et al. (2020b)
|
5, 10 μg/ml |
In vitro
|
LoVo cells SW 620 cells |
5, 10 μg/ml |
In vitro
|
Scutellarin |
Erigerontis Herba |
HCT 116 cells |
20–100 µM |
In vitro
|
Reduce viability and induce apoptosis, reduce Bcl-2, and increase Bax and phosphorylation of p53 |
Yang et al. (2017)
|
Paeonol |
Salvia miltiorrhiza Bge. |
HCT 116 cells |
7.8125–500 μg/ml |
In vitro
|
Induce G0/G1 phase arrest and cell apoptosis by inhibiting the Wnt/β-catenin signaling pathway |
Liu et al. (2020b)
|